Pluri Inc. (PLUR)
NASDAQ: PLUR
· Real-Time Price · USD
4.21
-0.19 (-4.32%)
At close: Jun 16, 2025, 3:56 PM
4.21
0.00%
After-hours: Jun 16, 2025, 04:04 PM EDT
-4.32% (1D)
| Bid | 4 |
| Market Cap | 32.98M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -20.9M |
| EPS (ttm) | -3.63 |
| PE Ratio (ttm) | -1.16 |
| Forward PE | -1.71 |
| Analyst | Buy |
| Ask | 4.95 |
| Volume | 19,665 |
| Avg. Volume (20D) | 19,073 |
| Open | 4.50 |
| Previous Close | 4.40 |
| Day's Range | 4.04 - 4.50 |
| 52-Week Range | 3.33 - 7.13 |
| Beta | 0.76 |
About PLUR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PLUR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PLUR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+4.76%
Pluri shares are trading higher after the company ...
Unlock content with
Pro Subscription
7 months ago
+11.84%
Brainstorm Cell Therapeutics and Pluri shares are trading higher after the companies entered into a memorandum of understanding to manufacture NurOwn for a Phase 3b trial in amyotrophic lateral sclerosis.
